Private clinic growth

Weight-loss injection services: regulation and safety

Offering GLP-1 weight-loss injections at a UK clinic: CQC registration, prescribing checks, advertising limits and the follow-up you owe patients.

Ava research teamPublished 7 min read

On this page
  1. Why clinics are being asked about injections every day
  2. Registration comes first
  3. The prescribing checks that protect you and the patient
  4. What you can and cannot say in marketing
  5. Follow-up is part of the service you sell
  6. The front desk is where safety starts
  7. Price the whole pathway, not the pen
  8. Working with a pharmacy partner
  9. When to decline or stop treatment
  10. Records and data
  11. A launch checklist
  12. Frequently asked questions
  13. References

Key takeaways

  • Demand is large: as many as 1.5 million people in the UK may be on private GLP-1 prescriptions[1].
  • A clinic that gives weight-reduction advice or treatment under a doctor is carrying on a regulated activity and must be registered[2][3].
  • You cannot advertise the medicine itself; promote the assessed weight-management service instead[4][5].
  • Build follow-up into the price and the diary before the first prescription, not after the first side effect.

Why clinics are being asked about injections every day

Government figures suggest as many as 1.5 million people in the UK are taking GLP-1 weight-loss medicines through private prescriptions[1]. Many found their provider online, and a growing number now ask local clinics and GP surgeries whether they can start, continue or switch treatment. Openness to private care in general has also risen: 71% of people say they would consider it if they needed treatment, up from 63% three years earlier[6].

People who would consider private healthcare if they needed treatment
People who would consider private healthcare if they needed treatmentComparison. Three years earlier: 63%; 2026: 71%.63%Three years earlierThree years earlier: 63%71%20262026: 71%People who would consider private healthcare if they needed treatmentComparison. Three years earlier: 63%; 2026: 71%.63%Three years earlierThree years earlier: 63%71%20262026: 71%

Source: Independent Healthcare Providers Network (IHPN), 2026[6]

Show the data
ItemValue
Three years earlier63%
202671%

That demand is an opportunity for a well-run clinic, but weight-loss injections combine three risk areas at once: prescription-only medicines, a regulated activity and an audience that is often vulnerable to pressure selling. The clinics that do this well treat it as a medical service with a long tail of follow-up, not as a product sale.

Registration comes first

In England, services provided in a slimming clinic that consist of advice or treatment by, or under the supervision of, a medical practitioner are a regulated activity in their own right[2]. Carrying on a regulated activity without being registered is a criminal offence[3]. If your clinic is already registered for treatment of disease, disorder or injury, check whether your registration covers this service before you take bookings. Prescribing nurses and pharmacists working under a doctor-led service change who supervises, not whether the activity is regulated.

Scotland, Wales and Northern Ireland have their own regulators (Healthcare Improvement Scotland, Healthcare Inspectorate Wales and RQIA). If you run sites in more than one nation, map each site to its regulator before launch.

The prescribing checks that protect you and the patient

Most complaints and safety incidents in this area trace back to a weak first assessment. Write your checks down as a protocol the whole team can see, and make the booking flow collect the information the prescriber needs before the appointment.

A first-assessment checklist for a GLP-1 weight-management service
CheckWhy it mattersWhat to record
Verified weight and heightSelf-reported figures are the most common route to inappropriate supplyHow it was verified: in clinic, live video with scales, or a recent measured record
Licensed indicationEach product has BMI and comorbidity criteria in its licenceWhich criterion the patient meets and the source document
Medical history and medicinesSome histories and medicines make treatment unsafe or need extra monitoringPancreatitis, thyroid, gallbladder, diabetes medicines, pregnancy plans, eating disorder screening
Contraception and pregnancyTreatment is not for use in pregnancy, and some products affect oral contraceptionAdvice given and the patient's confirmation
Consent to inform the NHS GPThe GP holds the full record and prescribes other medicinesConsent given or refused, and the prescriber's decision if refused
Expectations and planPatients need to know the dose steps, side effects and what happens when they stopWritten plan given, review dates booked

If a patient will not let you contact their NHS GP, the prescriber has to decide whether it is still safe to prescribe without that information. Many services make consent to share a condition of treatment. Whatever you choose, write it into your protocol and apply it every time.

What you can and cannot say in marketing

Publishing an advertisement that is likely to lead to the use of a prescription-only medicine is prohibited[4]. The advertising rules apply to sponsored search results and social media as well as print[5], and the regulator treats almost every reference to a prescription-only medicine as promotion[5]. That includes brand names in hashtags, images of pens, and phrases such as 'skinny jab'.

  • Do promote a doctor-led weight-management consultation, the assessment process and the support you provide.
  • Do say that treatment, including whether any medicine is suitable, is decided after a clinical assessment.
  • Do not name a medicine, show packaging or pens, or use a price for a medicine in an advert.
  • Do not run time-limited offers that push people to start treatment quickly.
  • Do not target or accept bookings from under-18s if your service is adults-only, and check age at assessment.

Script for an enquiry that asks to buy a specific pen: 'We don't sell medicines on request. We offer a weight-management consultation with a prescriber, who will check your health history and measurements and talk through options, which may or may not include medication. Would you like me to explain how the assessment works?'

Follow-up is part of the service you sell

  1. Book the reviews at the start

    Put the dose-step reviews in the diary when the first prescription is issued, so the patient leaves with dates rather than a promise to call.

  2. Check before each dose increase

    Ask about nausea, vomiting, abdominal pain, hydration and food intake. Persistent severe abdominal pain needs same-day clinical advice, so give the patient the words to use and the number to call.

  3. Re-weigh with the same method

    Use the same verification method as at assessment so the trend is real. Record it in the clinical record, not a spreadsheet.

  4. Report suspected reactions

    Report suspected adverse reactions through the Yellow Card scheme and keep a log so your medical lead can spot patterns.

  5. Plan the stopping conversation

    Discuss what happens when treatment ends, including weight regain, before the patient reaches that point.

  6. Write to the GP at key points

    Send a short letter at start, at any significant change and at stopping, with consent.

The front desk is where safety starts

Reception and online enquiries set the tone. Callers often want speed and a price. Train staff to describe the process, never to promise a prescription, and to route anything clinical to a prescriber. Out of hours, an AI Employee such as Ava can explain how the assessment works and pass the enquiry to the team, without discussing medicines.

Example: a fictional two-room clinic in Leeds started a weight-management service and found that a third of enquiries asked for a named brand. It changed its web form to ask 'What would you like help with?' instead of listing products, and added a question about who the patient's NHS GP is. The share of first assessments that ended without a prescription fell because unsuitable callers were filtered out earlier, and complaint calls about refusals dropped.

Price the whole pathway, not the pen

Patients compare clinics on the monthly figure they see first, so the temptation is to show a low headline and add review fees later. That causes complaints when the second invoice arrives. Price the service as a pathway: assessment, prescribing, the reviews at each dose step, and the final review when treatment ends. Show what is included and what is not, such as blood tests if the prescriber needs them.

  • State whether the assessment fee is refunded or credited if the prescriber decides treatment is not suitable.
  • Explain how the cost changes as the dose rises, if it does.
  • Say what happens if a review is missed: does supply pause until the review is done?
  • Keep marketing about the service separate from any price for a named medicine.

Working with a pharmacy partner

Many clinics prescribe and then send the prescription to a partner pharmacy that dispenses and posts the medicine. That splits responsibility, so put it in writing. The agreement should cover who checks the prescription, how cold-chain delivery is handled, what the pharmacy does if it has a clinical concern, and how quickly it tells you about a delivery failure. Ask the pharmacy what checks it makes on weight and identity, so the two of you are not each assuming the other has done them.

Give patients one point of contact. A patient whose pen arrived warm should not be passed between the clinic and the pharmacy. Decide in advance who answers, who replaces the item and who records the incident.

When to decline or stop treatment

A safe service turns people away. Common reasons include a history that makes treatment unsafe, signs of an eating disorder, pregnancy or plans for pregnancy, a weight that does not meet the licence criteria, or a patient who will not attend reviews. Write a short, kind script for the prescriber, and offer an alternative such as lifestyle support or a conversation with the NHS GP. Record the reason so that a second application through a different email address can be spotted.

Stopping should also be planned. If a patient has side effects they cannot tolerate, stops attending, or reaches the end of the planned course, write to them and, with consent, to their GP, so the next clinician knows what happened.

Records and data

Weight, medical history and prescribing data are health data, a special category under UK GDPR that you may only process when a specific condition applies[7]. Keep assessment photos and scale images in the clinical system, set a retention period, and make sure third-party pharmacies or courier partners are under a written contract. If you use an online questionnaire, check what the form provider stores and where.

A launch checklist

  1. Registration confirmed for each site and the named medical lead agreed.
  2. Written prescribing protocol, signed off and reviewed every six months.
  3. Booking flow collects history, GP details and consent before the appointment.
  4. Advertising reviewed against the prescription-only medicine rules.
  5. Review appointments and side-effect advice built into the patient pathway.
  6. Complaints, refunds and stopping policies written in plain English.

Frequently asked questions

Does a clinic need CQC registration to offer weight-loss injections?

In England, advice or treatment for weight reduction given by or under the supervision of a doctor in a slimming clinic is a regulated activity, so the provider must be registered[2]. Check that your registration covers it before you start.

Can we advertise weight-loss injections on social media?

No. Advertising likely to lead to the use of a prescription-only medicine is prohibited, including on social media and paid search[4][5]. You can promote an assessed weight-management service without naming medicines.

Should we tell the patient's NHS GP?

It is good practice and many services require consent to share as a condition of treatment, because the GP holds the full record. If a patient refuses, the prescriber must decide whether prescribing is still safe.

What follow-up should we offer?

Reviews before each dose increase, side-effect checks, re-weighing by the same method, reporting of suspected reactions and a planned conversation about stopping.

References

  1. GOV.UK (Department of Health and Social Care) (2025). Fit for the future: 10 Year Health Plan for England (opens in a new tab) ↑

  2. legislation.gov.uk (The National Archives) (2014). The Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, Schedule 1, paragraph 12: services in slimming clinics (opens in a new tab) ↑

  3. legislation.gov.uk (The National Archives) (2008). Health and Social Care Act 2008, section 10: requirement to register as a service provider (opens in a new tab) ↑

  4. legislation.gov.uk (The National Archives) (2012). The Human Medicines Regulations 2012, regulation 284: advertising of prescription only medicines (opens in a new tab) ↑

  5. Advertising Standards Authority (ASA) / CAP (2026). Healthcare: Prescription-only medicine (opens in a new tab) ↑

  6. Independent Healthcare Providers Network (IHPN) (2026). Support for using private healthcare now found across the political spectrum, new report shows (opens in a new tab) ↑

  7. legislation.gov.uk (The National Archives) (2026). UK GDPR Article 9: Processing of special categories of personal data (opens in a new tab) ↑

Book a demo

See Ava handle your calls.

Book a short demo. We’ll walk through your calls and workflow, and agree what Ava should take care of.

Book a demo